Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Jingquan Jia"'
Autor:
Elle C. Moore, Gerard C. Blobe, Nicholas C. DeVito, Brent A. Hanks, Michael R. Harrison, Christopher J. Hoimes, Jingquan Jia, Michael A. Morse, Parvathy Jayaprakasan, Andrew MacKelfresh, Hillary Mulder, Adam J. Hockenberry, Alia Zander, Martin C. Stumpe, Jackson Michuda, Kyle A. Beauchamp, Eric Perakslis, Timothy Taxter, Daniel J. George
Publikováno v:
Cancer Medicine, Vol 12, Iss 19, Pp 19394-19405 (2023)
Abstract Background Roughly 5% of metastatic cancers present with uncertain origin, for which molecular classification could influence subsequent management; however, prior studies of molecular diagnostic classifiers have reported mixed results with
Externí odkaz:
https://doaj.org/article/b59390dd42bb4274953a6323c81735b6
Publikováno v:
Frontiers in Oncology, Vol 8 (2018)
MET amplification is rare in treatment-naïve metastatic colorectal cancer (CRC) tumors, but can emerge as a mechanism of resistance to anti-EGFR therapies. Preclinical and clinical data suggest that patients with MET amplified tumors benefit from ME
Externí odkaz:
https://doaj.org/article/c8148f9916b94804b50aaa1ccf125047
Autor:
Andrew B. Nixon, Herbert I. Hurwitz, Herbert Pang, Neal Kaplan, Leigh A. Howard, Haiyan Li, Christel Rushing, Anuradha Bulusu, Eric S. Weiss, Andrew E. Dellinger, Jingquan Jia
Supplemental Table 2. BEE study patients and the number of patients whose granulation tissue biopsies were available for biomarker study.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::708584ef406333d73a27f88ad898df07
https://doi.org/10.1158/1078-0432.22454360
https://doi.org/10.1158/1078-0432.22454360
Autor:
Andrew B. Nixon, Herbert I. Hurwitz, Herbert Pang, Neal Kaplan, Leigh A. Howard, Haiyan Li, Christel Rushing, Anuradha Bulusu, Eric S. Weiss, Andrew E. Dellinger, Jingquan Jia
Supplemental Figure 1. Changes in average vascular score (AVS) from baseline.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::26eff214b517c7d06d4f55b14a253a82
https://doi.org/10.1158/1078-0432.22454366.v1
https://doi.org/10.1158/1078-0432.22454366.v1
Autor:
Andrew B. Nixon, Herbert I. Hurwitz, Herbert Pang, Neal Kaplan, Leigh A. Howard, Haiyan Li, Christel Rushing, Anuradha Bulusu, Eric S. Weiss, Andrew E. Dellinger, Jingquan Jia
Supplemental Table 3. BEP study patients and the number of patients whose granulation tissue biopsies were available for biomarker study.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5df6eb72e316bcea3e0638790d1ec422
https://doi.org/10.1158/1078-0432.22454357.v1
https://doi.org/10.1158/1078-0432.22454357.v1
Autor:
Andrew B. Nixon, Herbert I. Hurwitz, Herbert Pang, Neal Kaplan, Leigh A. Howard, Haiyan Li, Christel Rushing, Anuradha Bulusu, Eric S. Weiss, Andrew E. Dellinger, Jingquan Jia
Purpose: In early clinical testing, most novel targeted anticancer therapies have limited toxicities and limited efficacy, which complicates dose and schedule selection for these agents. Confirmation of target inhibition is critical for rational drug
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e037367bdadedd94b0392e20816e696
https://doi.org/10.1158/1078-0432.c.6522734
https://doi.org/10.1158/1078-0432.c.6522734
Autor:
Andrew B. Nixon, Herbert I. Hurwitz, Herbert Pang, Neal Kaplan, Leigh A. Howard, Haiyan Li, Christel Rushing, Anuradha Bulusu, Eric S. Weiss, Andrew E. Dellinger, Jingquan Jia
Supplemental Table 1. Characteristics of patients whose granulation tissue biopsies were available for biomarker analysis and patients whose average vascular score (AVS) were available.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ba0abb37f51291330acb262b246dcc9
https://doi.org/10.1158/1078-0432.22454363.v1
https://doi.org/10.1158/1078-0432.22454363.v1
Autor:
Jingquan Jia, Lauren Howard, Yingmiao Liu, Mark D. Starr, John C. Brady, Donna Niedzwiecki, John H. Strickler, Andrew B. Nixon
Publikováno v:
Cancer Chemotherapy and Pharmacology. 89:413-422
Autor:
Kristen Keon Ciombor, Tyler J. Zemla, Joleen M. Hubbard, Jingquan Jia, Olumide B. Gbolahan, Andrea Sousa, Luke Wilson, Blake Waechter, Fang-Shu Ou, Andrew B. Nixon, Tanios S. Bekaii-Saab
Publikováno v:
Journal of Clinical Oncology. 41:139-139
139 Background: The fibroblast growth factor receptor (FGFR) pathway plays a key role in cellular proliferation, migration, survival and angiogenesis. Aberrant signaling through FGFR in colorectal cancer and other malignancies results from gene ampli
Publikováno v:
Cancer Journal; Jul/Aug2024, Vol. 30 Issue 4, p251-252, 2p